Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2012
09/05/2012CN102652770A Jujube dead leaf wine
09/05/2012CN102652758A Application of health care drinking liquid containing deep seawater in preparation of medicaments or health care products for preventing or treating hyperlipidemia
09/05/2012CN102652757A Application of health-care drinking liquid containing deep seawater in preparation of medicaments or health-care products for preventing or treating metabolic syndrome
09/05/2012CN102652749A Application of 2-cycloxyl substituted or cyclothio substituted hydroxyacetophenone in treatment of metabolic disease
09/05/2012CN102652747A Compound medicinal composition for treating hypertension
09/05/2012CN102652744A Modified injection containing 13 compound vitamins and preparation method thereof
09/05/2012CN102302168B Vitamin d2 oil and preparation method thereof
09/05/2012CN102247394B Medical application of Harpagoside ingredient
09/05/2012CN102240358B Chinese medicinal blood fat removing and blood stasis eliminating mixture for treating hyperlipemia
09/05/2012CN102188649B Preparation method of traditional Chinese medicine for treating meat-accumulation type hyperlipidemia
09/05/2012CN102106818B Isoliquiritigenin micro-emulsion composition
09/05/2012CN102091103B Method for preparing gingko extract with low acid number by ultrasonic extraction
09/05/2012CN102091082B Ginsenoside Rb3 composition and application thereof in preparing medicament for treating diabetes
09/05/2012CN102060913B Heptapeptide combined with human serum albumin and application thereof
09/05/2012CN101972316B Traditional Chinese medicinal composition, use of traditional Chinese medicinal preparation
09/05/2012CN101972315B Use of traditional Chinese medicinal composition
09/05/2012CN101961423B Pu'er tea extract and preparation method thereof
09/05/2012CN101961315B Ornithine aspartate liposome injection
09/05/2012CN101961059B Puer tea extract, preparation method and application
09/05/2012CN101918363B Phenyl acetamide derivative
09/05/2012CN101904844B Pharmaceutical composition for preventing or treating osteoporosis or obesity comprising phenyltetrazole derivative
09/05/2012CN101897673B Method for preparing vitamin C tablet
09/05/2012CN101780242B Health or medicine composition and preparation method and application thereof
09/05/2012CN101756955B Chinonin complex, preparation method and application thereof
09/05/2012CN101711738B Oral pharmaceutical composition of Fenofibrate
09/05/2012CN101638423B Phloridzin derivative as well as preparation method and application thereof
09/05/2012CN101595109B 7,8-dihydro-1,6-naphthyridin-5(6h)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase IV and methods
09/05/2012CN101589039B Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme A delta-9 desaturase
09/05/2012CN101522204B Kiwi extract
09/05/2012CN101505778B Hypoglycemic composition containing component originating in the bark of tree belonging to the genus acacia
09/05/2012CN101474235B Preparation of wild cactus polysaccharide extract and high-efficient serum cholesterol-reducing function
09/05/2012CN101467575B Hypoglycemic fat-regulating health-care nutrient tea and method for producing the same
09/05/2012CN101428137B Composition for diminishing neutral fat in blood
09/05/2012CN101357139B Multivitamin selenium-enriched active pearl oral preparation and preparation method thereof
09/05/2012CN101284003B Medicinal composition containing andrographolide derivatives and preparation method thereof and application
09/05/2012CN101199523B Medicament composition containing levorotatory ammonia chlorine horizon and atorvastatin and preparing method thereof
09/05/2012CN101144082B Recombination human ciliary neurotrophy factor, mutant and application thereof
09/05/2012CN101125207B Exendin or its analogs with polyethylene group and its preparation and application
09/05/2012CN101035557B Preparation method of pharmaceutical formulation comprising crystalline insulin and dissolved insulin
09/05/2012CN101015646B Preparation for treating hyperlipoidemia and its preparing process
09/04/2012US8258304 N-aryl piperidine substituted biphenylcarboxamides
09/04/2012US8258288 RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)
09/04/2012US8258262 N-terminally chemically modified protein compositions and methods
09/04/2012US8258177 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
09/04/2012US8258095 Method of controlling glycemia by ultrarapid acting insulin without adjusting an insulin dose for meal content
09/04/2012US8257758 Process for the extraction, purification and enzymatic modification of soy 7S globulin alpha' subunit for use as hypocholesterolemizing agent
09/04/2012US8257691 Composition and dosage form comprising a particle formulation and suspending vehicle
09/04/2012CA2676443C Atorvastatin calcium propylene glycol solvates
09/04/2012CA2621365C Compositions and methods for the sustained release of beta-alanine
09/04/2012CA2610646C Prevascularized devices and related methods
09/04/2012CA2507429C Use of carnitines for the prevention and/or treatment of disorders caused by the andropause
09/04/2012CA2471812C Targeted retrograde gene delivery to motor neurons
09/04/2012CA2196999C Treatment of type ii diabetes mellitus with amylin agonists
08/2012
08/30/2012WO2012116176A2 Asymmetric ureas and medical uses thereof
08/30/2012WO2012115641A1 Lis-pro proinsulin compositions and methods of producing lis-pro insulin analogs therefrom
08/30/2012WO2012115249A1 Crystal of spiroketal derivative
08/30/2012WO2012115241A1 Fcγriib-specific fc antibody
08/30/2012WO2012115209A1 Soluble epoxide hydrolase inhibitor
08/30/2012WO2012115064A1 Ppar activator
08/30/2012WO2012115026A1 Tomatoside a-containing composition
08/30/2012WO2012114926A1 Thioamide compound, method for producing thioamide compound, method for producing [(4r,6r)-6-aminoethyl-1,3-dioxane-4-yl]acetate derivative, and method for producing atorvastatin
08/30/2012WO2012114131A1 Lecithin:cholesterol acyltransferase (lcat) and its role in nonalcoholic fatty liver disease (nafld)
08/30/2012WO2012113963A1 Use of p53 inhibitors for reducing food intake and lowering body weight
08/30/2012WO2012113286A1 A glp-1 analogue, its preparation methods and use thereof
08/30/2012WO2012113117A1 Oral preparation comprising protein or polypeptide, preparation method thereof, and use thereof
08/30/2012WO2012113116A1 Emulsion containing hydrophilic biological macromolecule, preparation method and application thereof
08/30/2012WO2012113103A1 Asymmetric ureas and medical uses thereof
08/30/2012WO2012094081A3 System and method for identifying and applying peripheral treatment mechanisms for disease
08/30/2012US20120222142 Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same
08/30/2012US20120220661 Methods of modulation of branched chain acids and uses thereof
08/30/2012US20120220651 Desferrioxamine-metal complexes for the treatment of immune-related disorders
08/30/2012US20120220650 Functional microbially fermented tea extract containing polyphenol derivative and method for producing the same
08/30/2012US20120220642 Amino Acid Compounds
08/30/2012US20120220632 Methods For Treatment of Fabry Disease
08/30/2012US20120220629 Asymmetric ureas and medical uses thereof
08/30/2012US20120220626 Novel quinoline compound, and composition containing centipede extract or compounds isolated therefrom for prevention and treatment of cardiovascular disease
08/30/2012US20120220616 Novel spiropiperidine compounds
08/30/2012US20120220614 Substituted biaryl derivatives and methods of use thereof
08/30/2012US20120220602 Cysteine protease inhibitors
08/30/2012US20120220593 Substituted Acrylamide Derivative and Pharmaceutical Composition Comprising the Same
08/30/2012US20120220591 Pyrimidone compounds
08/30/2012US20120220589 Heterocyclic compounds for the inhibition of pask
08/30/2012US20120220581 IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
08/30/2012US20120220580 Preparation of carotenoid derivatives and their applications
08/30/2012US20120220568 Histamine-3 Receptor Antagonists
08/30/2012US20120220567 Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
08/30/2012US20120220560 Steroid tetrol solid state forms
08/30/2012US20120220559 Controlled Release and Taste Masking Oral Pharmaceutical Composition
08/30/2012US20120220547 Food formulation comprising glycogen
08/30/2012US20120220522 Ester insulin
08/30/2012US20120219624 Process for preparing products comprising stabilised actives and compositions comprising same
08/30/2012US20120219623 Pharmaceutical compositions comprising bi-1356 and metformin
08/30/2012US20120219622 Dpp iv inhibitor formulations
08/30/2012US20120219621 Composition with Enhanced Thermogenic Activity and the Use Thereof in the Prevention and Treatment of Obesity
08/30/2012US20120219619 Substances for reducing occurrence of major cardiac events in humans
08/30/2012US20120219616 LIPOSOMAL REDUCED GLUTATHIONE AND l-ARGININE, INCLUDING WITH OTHER INGREDIENT(S), CAPABLE OF MULTIPATH ADMINISTRATION FOR REVERSAL AND PREVENTION OF OBESITY AND FOR MITOCHONDRIAL BIOGENESIS
08/30/2012US20120219593 Indolylmaleimide derivatives processes for their production and pharmaceutical compositions
08/30/2012US20120219592 Use of B-Aminoalcohols in the Treatment of Inflammatory Disorders and Pain
08/30/2012US20120219573 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
08/30/2012US20120219564 Human Antibodies That Bind Human TNFalpha
1 ... 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 ... 1298